Article
PHN-0003
2026-10-28 16:12 CT
Regulators review expanded cardiovascular labeling for semaglutide
Reuters
A label expansion is under review based on cardiovascular outcomes data.
NoticeInformation only. Not medical advice. Nothing here is a recommendation to use any substance. Read full disclaimer
1 items
Reuters
A label expansion is under review based on cardiovascular outcomes data.